SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Healthcare Services Group Inc. – ‘10-Q’ for 9/30/23 – ‘EX-31.2’

On:  Friday, 10/27/23, at 4:33pm ET   ·   For:  9/30/23   ·   Accession #:  731012-23-119   ·   File #:  0-12015

Previous ‘10-Q’:  ‘10-Q’ on 7/28/23 for 6/30/23   ·   Next & Latest:  ‘10-Q’ on 4/26/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/27/23  Healthcare Services Group Inc.    10-Q        9/30/23   83:8.7M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.53M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
10: R1          Cover Page                                          HTML     77K 
11: R2          Consolidated Balance Sheets                         HTML    136K 
12: R3          Consolidated Balance Sheets (Parenthetical)         HTML     42K 
13: R4          Consolidated Statements of Comprehensive (Loss)     HTML     93K 
                Income                                                           
14: R5          Consolidated Statements of Cash Flows               HTML    117K 
15: R6          Consolidated Statements of Stockholders' Equity     HTML    125K 
16: R7          Consolidated Statements of Stockholders' Equity     HTML     25K 
                (Parenthetical)                                                  
17: R8          Description of Business and Significant Accounting  HTML     49K 
                Policies                                                         
18: R9          Revenue                                             HTML     39K 
19: R10         Accounts and Notes Receivable                       HTML     39K 
20: R11         Allowance for Doubtful Accounts                     HTML    143K 
21: R12         Changes in Accumulated Other Comprehensive (Loss)   HTML     48K 
                Income by Component                                              
22: R13         Property and Equipment                              HTML     38K 
23: R14         Leases                                              HTML     59K 
24: R15         Goodwill and Other Intangible Assets                HTML     33K 
25: R16         Fair Value Measurements                             HTML    134K 
26: R17         Share-Based Compensation                            HTML     98K 
27: R18         Income Taxes                                        HTML     30K 
28: R19         Segment Information                                 HTML     55K 
29: R20         Earnings (Loss) Per Common Share                    HTML     54K 
30: R21         Other Contingencies                                 HTML     31K 
31: R22         Subsequent Events                                   HTML     26K 
32: R23         Pay vs Performance Disclosure                       HTML     36K 
33: R24         Insider Trading Arrangements                        HTML     29K 
34: R25         Description of Business and Significant Accounting  HTML     93K 
                Policies (Policies)                                              
35: R26         Accounts and Notes Receivable (Tables)              HTML     37K 
36: R27         Allowance for Doubtful Accounts (Tables)            HTML    220K 
37: R28         Changes in Accumulated Other Comprehensive (Loss)   HTML     49K 
                Income by Component (Tables)                                     
38: R29         Property and Equipment (Tables)                     HTML     35K 
39: R30         Leases (Tables)                                     HTML     60K 
40: R31         Goodwill and Other Intangible Assets (Tables)       HTML     32K 
41: R32         Fair Value Measurements (Tables)                    HTML    136K 
42: R33         Share-Based Compensation (Tables)                   HTML    106K 
43: R34         Segment Information (Tables)                        HTML     50K 
44: R35         Earnings (Loss) Per Common Share (Tables)           HTML     55K 
45: R36         Description of Business and Significant Accounting  HTML     59K 
                Policies (Details)                                               
46: R37         Revenue - Additional Information (Details)          HTML     70K 
47: R38         Revenue - Transaction Price Allocated to Remaining  HTML     31K 
                Performance Obligations (Details)                                
48: R39         Accounts and Notes Receivable - Schedule of         HTML     40K 
                Accounts and Notes Receivable (Details)                          
49: R40         Allowance for Doubtful Accounts - Additional        HTML     25K 
                Information (Details)                                            
50: R41         Allowance for Doubtful Accounts - Notes Receivable  HTML    103K 
                Disaggregated by Vintage Year (Details)                          
51: R42         Allowance for Doubtful Accounts - Age Analysis of   HTML     48K 
                Past-Due Note Receivable (Details)                               
52: R43         Allowance for Doubtful Accounts - Schedule of       HTML     66K 
                Changes in Allowance for Notes Receivable                        
                (Details)                                                        
53: R44         Changes in Accumulated Other Comprehensive (Loss)   HTML     46K 
                Income by Component - Accumulated Other                          
                Comprehensive Income (Details)                                   
54: R45         Changes in Accumulated Other Comprehensive (Loss)   HTML     50K 
                Income by Component - Reclassification Adjustments               
                (Details)                                                        
55: R46         Property and Equipment (Details)                    HTML     49K 
56: R47         Leases - Additional Information (Details)           HTML     36K 
57: R48         Leases - Components of Lease Expense (Details)      HTML     41K 
58: R49         Leases - Schedule of Future Minimum Lease Payments  HTML     44K 
                (Details)                                                        
59: R50         Goodwill and Other Intangible Assets - Additional   HTML     38K 
                Details (Details)                                                
60: R51         Goodwill and Other Intangible Assets - Estimated    HTML     39K 
                Amortization Expense For Intangibles Subject To                  
                Amortization (Details)                                           
61: R52         Fair Value Measurements - Additional Information    HTML     43K 
                (Details)                                                        
62: R53         Fair Value Measurements - Fair Value Measurements   HTML    119K 
                Information for Marketable Securities and Deferred               
                Compensation Fund Investments (Details)                          
63: R54         Fair Value Measurements - Marketable Debt           HTML     40K 
                Securities (Details)                                             
64: R55         Fair Value Measurements - Contractual Maturities    HTML     37K 
                of Debt Securities (Details)                                     
65: R56         Share-Based Compensation - Schedule of Stock-Based  HTML     47K 
                Compensation Expense (Details)                                   
66: R57         Share-Based Compensation - Additional Information   HTML     91K 
                (Details)                                                        
67: R58         Share-Based Compensation - Schedule of Stock        HTML     50K 
                Options Outstanding (Details)                                    
68: R59         Share-Based Compensation - Assumptions for Fair     HTML     33K 
                Value of Options Granted (Details)                               
69: R60         Share-Based Compensation - Summarized Other         HTML     40K 
                Information About Stock Options (Details)                        
70: R61         Share-Based Compensation - Schedule of Restricted   HTML     48K 
                Stock Units (Details)                                            
71: R62         Share-Based Compensation - Schedule of Outstanding  HTML     48K 
                Performance Stock Units (Details)                                
72: R63         Share-Based Compensation - Options Granted Under    HTML     44K 
                Employee Stock Purchase Plan (Details)                           
73: R64         Share-Based Compensation - Supplemental Employee    HTML     30K 
                Retirement Plan (Details)                                        
74: R65         Income Taxes (Details)                              HTML     27K 
75: R66         Segment Information - Schedule of Segment           HTML     48K 
                Information (Details)                                            
76: R67         Earnings (Loss) Per Common Share - Schedule of      HTML     59K 
                Weighted Average Basic and Diluted Common Shares                 
                Outstanding (Details)                                            
77: R68         Earnings (Loss) Per Common Share - Schedule         HTML     26K 
                Anti-dilutive Outstanding Equity Awards Under                    
                Share Based Compensation Plans (Details)                         
78: R69         Other Contingencies (Details)                       HTML     42K 
81: XML         IDEA XML File -- Filing Summary                      XML    152K 
79: XML         XBRL Instance -- hcsg-20230930_htm                   XML   2.17M 
80: EXCEL       IDEA Workbook of Financial Report Info              XLSX    158K 
 6: EX-101.CAL  XBRL Calculations -- hcsg-20230930_cal               XML    237K 
 7: EX-101.DEF  XBRL Definitions -- hcsg-20230930_def                XML    567K 
 8: EX-101.LAB  XBRL Labels -- hcsg-20230930_lab                     XML   1.92M 
 9: EX-101.PRE  XBRL Presentations -- hcsg-20230930_pre              XML   1.10M 
 5: EX-101.SCH  XBRL Schema -- hcsg-20230930                         XSD    166K 
82: JSON        XBRL Instance as JSON Data -- MetaLinks              553±   829K 
83: ZIP         XBRL Zipped Folder -- 0000731012-23-000119-xbrl      Zip    347K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 31.2

Certification of the Principal Financial Officer
Pursuant to Rules 13a-14(a) and 15d-14(a)
Under the Securities Exchange Act, as Amended

I, Andrew M. Brophy, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Services Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date:October 27, 2023/s/ Andrew M. Brophy
Andrew M. Brophy
Principal Accounting Officer
(Principal Financial and Accounting Officer)




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/27/23
For Period end:9/30/234
 List all Filings 
Top
Filing Submission 0000731012-23-000119   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 2:15:26.1am ET